---
figid: PMC5726441__nihms895027f6
figlink: /pmc/articles/PMC5726441/figure/F6/
number: F6
caption: Adaptive resistance (in green, also labeled “1”) often involves upregulation
  of upstream regulators, including RTKs (HER3, INSR, IGF-1R), IRS-1, JAK2, or SRC
  by disruption of negative-feedback loops. Primary or acquired resistance (in red,
  “2”) can arise by expression or activation of kinases with downstream targets in
  common with AKT or mTORC1 (SGK1, PDK1, PIM1), constitutive activation of mTORC1
  signaling (e.g., due to loss of TSC function), or loss of PTEN expression. Primary
  or acquired resistance (in orange, “3”) can also arise by PI3K isoform switching;
  selective inhibition of p110α can lead to substitution by p110β or vice versa. Finally,
  primary or acquired resistance can also arise by activation of heterologous pathways
  leading to common endpoints; for instance, MYC-dependent transcriptional activation
  or ERK activity (in pink, “4”).
pmcid: PMC5726441
papertitle: The PI3K pathway in human disease.
reftext: David A. Fruman, et al. Cell. ;170(4):605-635.
pmc_ranked_result_index: '28485'
pathway_score: 0.9515482
filename: nihms895027f6.jpg
figtitle: PI3K pathway in human disease
year: ''
organisms:
- Homo sapiens
ndex: 769ad82e-def3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5726441__nihms895027f6.html
  '@type': Dataset
  description: Adaptive resistance (in green, also labeled “1”) often involves upregulation
    of upstream regulators, including RTKs (HER3, INSR, IGF-1R), IRS-1, JAK2, or SRC
    by disruption of negative-feedback loops. Primary or acquired resistance (in red,
    “2”) can arise by expression or activation of kinases with downstream targets
    in common with AKT or mTORC1 (SGK1, PDK1, PIM1), constitutive activation of mTORC1
    signaling (e.g., due to loss of TSC function), or loss of PTEN expression. Primary
    or acquired resistance (in orange, “3”) can also arise by PI3K isoform switching;
    selective inhibition of p110α can lead to substitution by p110β or vice versa.
    Finally, primary or acquired resistance can also arise by activation of heterologous
    pathways leading to common endpoints; for instance, MYC-dependent transcriptional
    activation or ERK activity (in pink, “4”).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NRAS
  - BAD
  - KRAS
  - AKT2
  - SGK1
  - HRAS
  - MTOR
  - FOXO6
  - ARAF
  - MAPK3
  - MAPK1
  - PTEN
  - RAF1
  - MAP2K2
  - RPTOR
  - AKT3
  - RICTOR
  - BRAF
  - AKT1S1
  - SRC
  - AKT1
  - FOXO4
  - FOXO1
  - EIF4EBP1
  - PDK1
  - MYC
  - JAK2
  - MAP2K1
  - FOXO3
  - MAPKAP1
  - MLST8
  - IRS1
  - PIM1
  - TSC1
  - TSC2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: '*RAS'
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: '*RAS'
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: SGK1
  symbol: SGK1
  source: hgnc_symbol
  hgnc_symbol: SGK1
  entrez: '6446'
- word: '*RAS'
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PRAS40
  symbol: PRAS40
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1S1
  entrez: '84335'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: IRS1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PIM1
  symbol: PIM1
  source: hgnc_symbol
  hgnc_symbol: PIM1
  entrez: '5292'
- word: TSC
  symbol: TSC
  source: bioentities_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: TSC
  symbol: TSC
  source: bioentities_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5726441__F6
redirect_from: /figures/PMC5726441__F6
figtype: Figure
---
